Press "Enter" to skip to content

Posts published in “Health”

Pfizer’s COVID vaccine demonstrates efficacy in clinical trials. Now what?

Last Monday, Pfizer announced preliminary findings from Phase III of clinical trials demonstrate that its SARS-CoV2 vaccine is effective in producing antibodies against COVID. Pfizer partnered with German biotech firm, BioNTech, to produce the vaccine. Pfizer is one of the two forerunners in Phase III of clinical trials to prove efficacy of an mRNA vaccine. The other being Moderna. mRNA vaccines are developed from re-engineered messenger RNA (mRNA), the molecules that relay genetic instructions from DNA to the cell’s protein-making machinery. The company’s technology sends synthetic mRNA into cells, which would hypothetically invoke an immune response that causes the body to develop antibodies against the virus.…

Moderna’s Race for a Covid Vaccine: A Fireside Chat with Lavina Talukdar, Head of Investor Relations

On November 4th, Stern Healthcare Association (SHA) hosted a fireside chat with Moderna’s Head of Investor Relations, Lavina Talukdar. Ms.Talukdar joined Moderna in April 2019 after 20 years as a biotech and healthcare investor. She is an expert in the niche market of investment procurement for mRNA development. Professor Viral Acharya moderated the discussion. Professor Acharya is the C.V. Starr Professor of Economics in the Department of Finance at Stern and an Academic Advisor to the Federal Reserve Banks of New York and Philadelphia. The week of the event, he published a paper on the economic value a SARS-CoV-2 vaccine would bring to society. …

The Pandemic Blues

I think we can all agree that the past seven months have not been easy for anyone. Humans are, for the most part, social creatures, so it’s difficult to maintain an emotional equilibrium when we lose regular contact with others. Zoom just doesn’t cut it. Many of us have noted more lability in our moods, and some may even consider themselves depressed. This is all normal and even to be expected. In fact, the medical community has a term for it – adjustment disorder.

Adjustment disorders are stress-related conditions. When an individual experiences more stress than usual, related to an event or circumstances, it can trigger an emotional response and some neurochemical variability, leading to sustained feelings of being blue.…

The Race to Develop a SARS-CoV2 Vaccine

With no end to the Covid-19 pandemic in sight, the only solution to liberate us from SARS-CoV2, the novel coronavirus, appears to be a vaccine. Creating a vaccine, however, is no easy feat. The record time for developing a vaccine, which resulted in an effective vaccine for mumps, is four years. Ordinarily, vaccine formulation and clinical trials, proving it efficacious, take 10-15 years. Operation Warp Speed is hoping to truncate this process to under a year.

The typical process for producing a vaccine, or any medication, is meticulous and extensive. It begins with research and development as well as capital procurement.…

Reflecting on the SHA Alumni Career Insights Panel

By Prashant Kota

Last week, the Stern Healthcare Association (SHA) hosted an alumni career insights panel to guide those MBA students interested in careers in the healthcare industry amidst the rapidly changing healthcare landscape. I was fortunate to have had the opportunity to moderate the panel, and we were lucky enough to hear from healthcare industry leaders such as Tim Nolan from EmblemHealth, Pooja Chatterjee from Abbott, and Josh Kurtzig from United Family Healthcare. 

Tim, a health insurance expert with over 30 years of experience in healthcare, leads EmblemHealth’s efforts in revenue growth and clinical and provider network as EmblemHealth’s Executive Vice President.…

Mission News Theme by Compete Themes.